Evidence map›Paper›PMID 33074415›Full record

ArticleApplied microbiology and biotechnology2020

Transdermal peptide conjugated to human connective tissue growth factor with enhanced cell proliferation and hyaluronic acid synthesis activities produced by a silkworm silk gland bioreactor.

Yuancheng Wang, Feng Wang, Sheng Xu, Riyuan Wang, Chi Tian, Yanting Ji, Qianqian Yang, Ping Zhao, Qingyou Xia

Abstract read
PubMed Publisher
In one paragraph

Article in Applied microbiology and biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 45% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Application of Transgenic Silk Fibroin to Biomaterials.Biotechnology and bioengineering · 2026
    Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Yuancheng WangBiological Science Research Center, Southwest University, Chongqing, 400715, People's Republic of China.
Feng WangBiological Science Research Center, Southwest University, Chongqing, 400715, People's Republic of China.
Sheng XuBiological Science Research Center, Southwest University, Chongqing, 400715, People's Republic of China.
Riyuan WangBiological Science Research Center, Southwest University, Chongqing, 400715, People's Republic of China.
Chi TianBiological Science Research Center, Southwest University, Chongqing, 400715, People's Republic of China.
Yanting JiBiological Science Research Center, Southwest University, Chongqing, 400715, People's Republic of China.
Qianqian YangBiological Science Research Center, Southwest University, Chongqing, 400715, People's Republic of China.
Ping ZhaoBiological Science Research Center, Southwest University, Chongqing, 400715, People's Republic of China.
Qingyou XiaBiological Science Research Center, Southwest University, Chongqing, 400715, People's Republic of China. xiaqy@swu.edu.cn.
Southwest University · CN

Funding

Chongqing Natural Science Foundation cstc2019jcyj-bshX0102Chongqing Science and Technology Commission cstc2018jcyjAX0298National Natural Science Foundation of China 31501896
6 · The paper itself

Abstract

Human connective tissue growth factor (CTGF) is a secreted cysteine-rich peptide that stimulates cell proliferation, migration, and extracellular matrix production during tissue development, differentiation, angiogenesis, implantation, wound healing, and fibrosis processes, with broad application in the medical and cosmetic medical fields. However, the production of CTGF is currently limited by its low yield and purity in current bioreactors. In this study, two genetically modified silkworm strains were generated harboring artificially designed CTGF-8ht and pepCTGF-8ht genes, respectively, that contain an enhanced His-tag with eight histidine residues with or without a transdermal peptide (pep). Both recombinant CTGF-8ht and pepCTGF-8ht proteins were successfully expressed in the silkworm silk gland and cocoon, and could be easily extracted and purified from the cocoon by single-affinity immunoprecipitation column chromatography, achieving a purity of more than 95%. Moreover, compared with CTGF-8ht protein, pepCTGF-8ht protein exhibited better cell proliferation activity by activating the extracellular signal-regulated kinase (ERK) pathway and enhanced hyaluronic acid synthesis activity by upregulating hyaluronan synthase 3 expression; moreover, the addition of pep significantly improved the transmembrane ability of CTGF-8ht protein. These results should help to promote the application prospects of CTGF and further guide the design and development of protein drugs from silkworm and other bioreactor systems. KEY POINTS : A silkworm bioreactor was optimized to produce connective tissue growth factor (CTGF) The transgene contained an enhanced 8-His-tag and transmembrane peptide (pep) Recombinant CTGF was easily purified with maintained or higher biological activity.

Indexed as

BioreactorsBombyxAnimalsCell ProliferationConnective Tissue Growth FactorHumansHyaluronic AcidRecombinant Fusion ProteinsSilkConnective Tissue Growth FactorHyaluronic AcidRecombinant Fusion ProteinsSilkGenetic engineeringHuman connective tissue growth factorSilkworm silk gland bioreactorTransdermal peptide

Identifiers

PMID33074415
OpenAlexW3092930411

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.